185 results on '"Dubois, Wendy"'
Search Results
2. WDR26 and MTF2 are therapeutic targets in multiple myeloma
3. FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells
4. Supplementary Table 1 from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
5. SupplementalFigures 1-4, Tables from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
6. supplementary methods from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
7. Data from Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
8. Supplementary Figures from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
9. Data from Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
10. Frap, FKBP12 Rapamycin-Associated Protein, Is a Candidate Gene for the Plasmacytoma Resistance Locus Pctr2 and Can Act as a Tumor Suppressor Gene
11. Supplementary Tables 1-3, Figures 1-6 from Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice
12. Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity
13. Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence
14. Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus
15. Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation
16. Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
17. Conditional deletion of mTOR discloses its essential role in early B‐cell development
18. IL-6 and MYC collaborate in plasma cell tumor formation in mice
19. Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility
20. Additional file 1 of WDR26 and MTF2 are therapeutic targets in multiple myeloma
21. Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress
22. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer
23. Conditional deletion of mTOR discloses its essential role in early B‐cell development.
24. Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis
25. Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression
26. Mouse tumor susceptibility genes identify drug combinations for multiple myeloma
27. Cover Image, Volume 59, Issue 2
28. Attenuation of immune‐mediated bone marrow damage in conventionally housed mice
29. The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility
30. Regulation of MicroRNA Expression and Abundance during Lymphopoiesis
31. CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms
32. Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas
33. ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells
34. mTOR intersects antibody-inducing signals from TACI in marginal zone B cells
35. Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
36. Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation
37. cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma
38. p53 Loss Increases the Osteogenic Differentiation of BMSCs
39. Abstract 322: Selective inhibition of MYC expression by a small molecule G-quadruplex stabilizer
40. Abstract 2833: Genetic and pharmacologic inhibition of mTOR delays mortality due to thymc lymphoma formation in mice and is associated with decreases in cell cycle proteins
41. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis
42. Abstract 2309: Murine model of dual mTORC kinase inhibition identifies CDK6 as a synergistic target in T-ALL
43. An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells
44. p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
45. B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity
46. Abstract 5472: Systems pharmacogenomics approach identifies synergistic molecular action of combined MTOR/HDAC inhibition on MYC
47. Abstract 2468: A p53 and microRNA-mediated pathway regulates mesenchymal stem cell differentiation
48. Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression
49. A Genome-wide Map of CTCF Multivalency Redefines the CTCF Code
50. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.